Fred Hassan

Insider Reports History

Location
C/O Caret Group,, 1100 Holland Dr., Boca Raton, FL
Signature
/s/ Fred Hassan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Fred Hassan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. Director Common Stock 1.15M $2.01M $1.74 Mar 14, 2025 Direct
Cocrystal Pharma, Inc. Director Common Stock 1.38M $1.92M $1.39 Oct 28, 2025 Direct
Cocrystal Pharma, Inc. Director Warrants 719K $1M $1.39 Oct 28, 2025 Direct
BridgeBio Pharma, Inc. Director Common Stock 25.9K $902K $34.85 Jun 20, 2025 Direct
PRECIGEN, INC. Director Restricted Stock Units 0 $0 $1.74 Mar 14, 2025 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 83.5K Mar 13, 2025 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Options (Right to buy) 60K Sep 3, 2024 Direct
EyePoint Pharmaceuticals, Inc. Director Stock Option (Right to Buy) 40K Jan 3, 2025 Direct
BridgeBio Pharma, Inc. Director Stock Option (Right to Buy) 8.43K Jun 20, 2025 Direct
Prometheus Biosciences, Inc. Director Common Stock 0 $108.42 Jun 16, 2023 Direct
Prometheus Biosciences, Inc. Director Stock Option (right to buy) 0 Jun 16, 2023 Direct

Insider Reports Filed by Fred Hassan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
COCP Cocrystal Pharma, Inc. Oct 28, 2025 2 $1.5M 4 Oct 30, 2025 Director
BBIO BridgeBio Pharma, Inc. Jun 20, 2025 2 $0 4 Jun 24, 2025 Director
PGEN PRECIGEN, INC. Mar 13, 2025 5 $63K 4 Mar 17, 2025 Director
EYPT EyePoint Pharmaceuticals, Inc. Jan 3, 2025 1 $0 4 Jan 7, 2025 Director
COCP Cocrystal Pharma, Inc. Oct 9, 2024 1 $0 4 Oct 11, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Sep 3, 2024 0 $0 3 Sep 5, 2024 Director
EYPT EyePoint Pharmaceuticals, Inc. Sep 3, 2024 1 $0 4 Sep 5, 2024 Director
BBIO BridgeBio Pharma, Inc. Jun 21, 2024 1 $0 4 Jun 25, 2024 Director
PGEN PRECIGEN, INC. Mar 14, 2024 3 $63K 4 Mar 18, 2024 Director
PGEN PRECIGEN, INC. Mar 9, 2024 2 $0 4 Mar 12, 2024 Director
PGEN PRECIGEN, INC. Aug 14, 2023 1 $998K 4 Aug 16, 2023 Director
COCP Cocrystal Pharma, Inc. Jul 18, 2023 1 $0 4 Jul 20, 2023 Director
BBIO BridgeBio Pharma, Inc. Jun 21, 2023 1 $0 4 Jun 23, 2023 Director
RXDX Prometheus Biosciences, Inc. Jun 16, 2023 4 $0 4 Jun 16, 2023 Director
RXDX Prometheus Biosciences, Inc. May 19, 2023 1 $0 4 May 19, 2023 Director
COCP Cocrystal Pharma, Inc. Apr 20, 2023 0 $0 3 Apr 27, 2023 Director
PGEN PRECIGEN, INC. Mar 9, 2023 3 $56.5K 4 Mar 13, 2023 Director
PGEN PRECIGEN, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
BBIO BridgeBio Pharma, Inc. Jun 22, 2022 1 $0 4 Jun 24, 2022 Director
RXDX Prometheus Biosciences, Inc. May 19, 2022 1 $0 4 May 20, 2022 Director
PGEN PRECIGEN, INC. Mar 25, 2022 2 $0 4 Mar 29, 2022 Director
PGEN PRECIGEN, INC. Feb 22, 2022 3 $56.5K 4 Feb 24, 2022 Director
BBIO BridgeBio Pharma, Inc. Dec 29, 2021 1 $273K 4 Jan 3, 2022 Director
RXDX Prometheus Biosciences, Inc. Nov 14, 2021 1 $0 4 Nov 16, 2021 Director
BBIO BridgeBio Pharma, Inc. Aug 17, 2021 1 $0 4 Aug 26, 2021 Director
BBIO BridgeBio Pharma, Inc. Aug 17, 2021 0 $0 3 Aug 26, 2021 Director
RXDX Prometheus Biosciences, Inc. May 14, 2021 1 $0 4 May 17, 2021 Director
RXDX Prometheus Biosciences, Inc. May 14, 2021 0 $0 3 May 17, 2021 Director